Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for determining drug efficacy using cereblon-associated proteins

Methods for determining drug efficacy using cereblon-associated proteins

US Patent 9857359 · Granted Jan 2, 2018

Estimated economic value: $545,291,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating multiple myeloma and the use of companion biomarkers for 4-2025
Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((22024
Methods for treating systemic lupus erythematosus and the use of biomarkers as a2024
Antiproliferative compounds and methods of use thereof2024
Transgenic mouse expressing human cereblon2024
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and me2024
Compositions and methods for inducing conformational changes in cereblon and oth2023
Methods for treating multiple myeloma and the use of companion biomarkers for 4-2023
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2023